Clinical Trial Update: Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing consistency, immunogenicity, and safety of GSK's herpes zoster vaccine in adults 50 and older; study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• GSK1437173A (GSK1437173A)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Zoster, Herpes Zoster Vaccine | Phase 3 | Status: COMPLETED | Results posted: 2017-05-24